Source comparison
TB-500 Dosage Cell Migration 2026: Protocol Comparison
| Protocol Type | Dose per Administration | Frequency | Total Weekly Dose | Migration Velocity Increase (vs Baseline) | Optimal Use Case | Professional Assessment ||—|—|—|—|—|—|| Low-Dose Titration | 2–2.5mg | Every 72 hours | 4.7–5.8mg | 1.8–2.2× baseline | I
This comparison does not assign a generated winner or score.
- | Protocol Type | Dose per Administration | Frequency | Total Weekly Dose | Migration Velocity Increase (vs Baseline) | Optimal Use Case | Professional Assessment ||—|—|—|—|—|—|| Low-Dose Titration | 2–2.5mg | Every 72 hours | 4.7–5.8mg | 1.8–2.2× baseline | Initial response testing, cell line characterisation | Identifies individual threshold before committing to full protocol. Essential for novel cell lines || Standard Migration Protocol | 5–7.5mg | Every 72 hours | 11.7–17.5mg | 2.8–3.2× baseline | Sustained migration assays, wound healing models | Gold standard for replicating published findings. Matches temporal actin cycles || High-Dose Extended Window | 10–12.5mg | Every 96 hours | 10.5–13.1mg | 2.9–3.3× baseline (extended 72h peak) | Long-duration imaging, minimal handling protocols | Extends peak activity window without increasing velocity. Useful when 96h intervals reduce handling stress || Daily Micro-Dosing | 2–2.5mg | Every 24 hours | 14–17.5mg | 1.9–2.4× baseline | Not re